For many of us in the medical writing profession, the impetus to hone our ability to communicate real-world evidence (RWE) may now be stronger than ever. At the beginning of 2020, ISPOR (the professional society for health economics and outcomes research) elevated RWE to #1 in their top 10 health economics and outcomes research trends for the year, emphasizing its high importance in health care decision-making. Medical science liaison teams in the pharmaceutical setting are increasingly requesting published RWE over other sources to support their scientific exchange with health care professionals and formulary decision-makers. This webinar will help medical writers understand the components of a compelling RWE publication, and how approaches to optimally communicating real-world data and randomized controlled trial data can differ.
After participating in this webinar, participants should be able to
- Discuss current trends in RWE generation and the types and importance of RWE
- Recognize key components of an RWE publication
- Apply best practice in communicating RWE studies in the medical literature